Two-hour diagnostic algorithms for early assessment of patients with acute chest pain - Implications of lowering the cardiac troponin I cut-off to the 97.5th percentile

Clinica Chimica Acta

Volumn 445, Issue , 2015, Pages 19-24

  Eggers, Kai M ^a   Aldous, Sally ^c   Greenslade, Jaimi H ^d,g   Johnston, Nina ^a   Lindahl, Bertil ^a,b   Parsonage, William A ^d,f   Pickering, John W ^c,e   Than, Martin ^c   Cullen, Louise ^d,f  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA CLINICAL RESEARCH CENTER   (Sweden)

^c CHRISTCHURCH HOSPITAL   (New Zealand)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f UNIVERSITY OF OTAGO   (New Zealand)

^g QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Cardiac troponin; Chest pain; Diagnosis; Emergency department; Myocardial infarction

Indexed keywords

BIOLOGICAL MARKER; HIGH SENSITIVITY CARDIAC TROPONIN I; TROPONIN I; UNCLASSIFIED DRUG;

ADULT; ALGORITHM; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATIENT ASSESSMENT; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; THORAX PAIN; ACUTE DISEASE; AGED; BLOOD; CHEST PAIN; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOLOGY; SURVIVAL;

NUCLEOPOLYHEDROVIRUS;

ACUTE DISEASE; AGED; ALGORITHMS; BIOMARKERS; CHEST PAIN; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; TROPONIN I;

EID: 84925219279     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.03.002     Document Type: Article

References (26)

1. Karlson B.W., Herlitz J., Pettersson P., Ekvall H.E., Hjalmarson A. Patients admitted to the emergency room with symptoms indicative of acute myocardial infarction. J Intern Med 1991, 230:251-258.
2. Body R., Carley S., McDowell G., et al. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J Am Coll Cardiol 2011;58:1332-9. Erratum in: J Am Coll Cardiol 2012;60:1122.
3. Reichlin T., Schindler C., Drexler B., et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med 2012, 172:1211-1218.
4. Meune C., Balmelli C., Vogler E., et al. Consideration of high-sensitivity troponin values below the 99th percentile at presentation: does it improve diagnostic accuracy?. Int J Cardiol 2013, 168:3752-3757.
5. Reichlin T., Cullen L., Parsonage W.A., et al. Two-hour algorithm for triage toward rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Am J Med 2014, [Published online]. 10.1016/j.amjmed.2014.10.032.
6. Apple F.S., Ler R., Murakami M.A. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 2012, 58:1574-1581.
7. Koerbin G., Abhayaratna W.P., Potter J.M., et al. Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays. Clin Biochem 2013, 46:1636-1643.
8. Zeller T., Tunstall-Pedoe H., Saarela O., et al. High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort. Eur Heart J 2014, 35:271-281.
9. Reichlin T., Twerenbold R., Maushart C., et al. Risk stratification in patients with unstable angina using absolute serial changes of 3 high-sensitive troponin assays. Am Heart J 2013, 165. [371-8.e3].
10. Bohula May E.A., Bonaca M.P., Jarolim P., et al. Prognostic performance of a high-sensitivity cardiac troponin assay in patients with non-ST-elevation acute coronary syndrome. Clin Chem 2014, 60:158-164.
11. Hickman P.E., Lindahl B., Potter J.M., Venge P., Koerbin G., Eggers K.M. Is it time to do away with the 99th percentile for cardiac troponin in the diagnosis of acute coronary syndrome and the assessment of cardiac risk?. Clin Chem 2014, 60:734-736.
12. Than M., Cullen L., Aldous S., et al. 2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial. J Am Coll Cardiol 2012, 59:2091-2098.
13. Uettwiller-Geiger D., Wu A.H., Apple F.S., et al. Multicenter evaluation of an automated assay for troponin I. Clin Chem 2002, 48:869-876.
14. Tate J.R. Troponin revisited 2008: assay performance. Clin Chem Lab Med 2008, 46:1489-1500.
15. Thygesen K., Alpert J.S., Jaffe A.S., et al. Third universal definition of myocardial infarction. Circulation 2012, 126:2020-2035.
16. Koerbin G., Tate J., Potter J.M., Cavanaugh J., Glasgow N., Hickman P.E. Characterisation of a highly sensitive troponin I assay and its application to a cardio-healthy population. Clin Chem Lab Med 2012, 50:871-878.
17. Krintus M., Kozinski M., Boudry P., et al. European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay. Clin Chem Lab Med 2014, 52:1657-1665.
18. Westgard J.O., Klee G.G. Quality management. Tietz textbook of clinical chemistry and molecular diagnostics 2006, 498-499. Elsevier Saunders, St. Louis, MO. 4th ed. C.A. Burtis, E.R. Ashwood, D.E. Bruns (Eds.).
19. Kavsak P.A., MacRae A.R. Letter by Kavsak and MacRae regarding article, "Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction". Circulation 2012, 125:e358.
20. Mingels A., Jacobs L., Michielsen E., Swaanenburg J., Wodzig W., van Dieijen-Visser M. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem 2009, 55:101-108.
21. Johnston N., Jernberg T., Lindahl B., et al. Biochemical indicators of cardiac and renal function in a healthy elderly population. Clin Biochem 2004, 37:210-216.
22. Jaffe A.S., Apple F.S., Morrow D.A., Lindahl B., Katus H.A. Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the definition of myocardial infarction. Clin Chem 2010, 56:941-943.
23. Nordenskjöld A.M., Ahlström H., Eggers K.M., et al. Short- and long-term individual variation in cardiac troponin in patients with stable coronary artery disease. Clin Chem 2013, 59:401-409.
24. Than M., Herbert M., Flaws D., et al. What is an acceptable risk of major adverse cardiac event in chest pain patients soon after discharge from the Emergency Department? A clinical survey. Int J Cardiol 2013, 166:752-754.
25. Korley F.K., Jaffe A.S. Preparing the United States for high-sensitivity cardiac troponin assays. J Am Coll Cardiol 2013, 61:1753-1758.
26. Kavsak P.A., Ko D.T., Wang X., MacRae A.R., Jaffe A.S. Increasing cardiac troponin changes measured by a research high-sensitivity troponin I assay: absolute vs percentage changes and long-term outcomes in a chest pain cohort. Clin Chem 2010, 56:1902-1904.